CollPlant Biotechnologies (CLGN) Finished Goods (2022 - 2025)

CollPlant Biotechnologies' Finished Goods history spans 4 years, with the latest figure at $290000.0 for Q4 2025.

  • For Q4 2025, Finished Goods rose 88.31% year-over-year to $290000.0; the TTM value through Dec 2025 reached $290000.0, up 88.31%, while the annual FY2025 figure was $290000.0, 88.31% up from the prior year.
  • Finished Goods reached $290000.0 in Q4 2025 per CLGN's latest filing, up from $154000.0 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $549000.0 in Q4 2022 to a low of $154000.0 in Q4 2024.
  • Average Finished Goods over 4 years is $383500.0, with a median of $415500.0 recorded in 2023.
  • Peak YoY movement for Finished Goods: crashed 71.53% in 2024, then skyrocketed 88.31% in 2025.
  • A 4-year view of Finished Goods shows it stood at $549000.0 in 2022, then dropped by 1.46% to $541000.0 in 2023, then plummeted by 71.53% to $154000.0 in 2024, then surged by 88.31% to $290000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLGN's Finished Goods are $290000.0 (Q4 2025), $154000.0 (Q4 2024), and $541000.0 (Q4 2023).